{
  "id": "af0be42249823077",
  "title": "Oncolytics Biotech\u00ae Receives FDA Fast Track Designation for Pelareorep in 2L KRAS - Mutant MSS Metastatic Colorectal Cancer",
  "description": "20260204T143000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/02/04/tmt-newswire/globenewswire/oncolytics-biotech-receives-fda-fast-track-designation-for-pelareorep-in-2l-kras-mutant-mss-metastatic-colorectal-cancer/2271698",
  "published_at": "20260204T143000Z",
  "fetched_at": "2026-02-05T00:29:17.336486+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/02/04/tmt-newswire/globenewswire/oncolytics-biotech-receives-fda-fast-track-designation-for-pelareorep-in-2l-kras-mutant-mss-metastatic-colorectal-cancer/2271698",
    "url_mobile": "https://www.manilatimes.net/2026/02/04/tmt-newswire/globenewswire/oncolytics-biotech-receives-fda-fast-track-designation-for-pelareorep-in-2l-kras-mutant-mss-metastatic-colorectal-cancer/2271698/amp",
    "title": "Oncolytics Biotech\u00ae Receives FDA Fast Track Designation for Pelareorep in 2L KRAS - Mutant MSS Metastatic Colorectal Cancer",
    "seendate": "20260204T143000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/02/04/925153.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}